CLINICAL_TRIALS
trial_result
· 2016-09-16
Clinical Trial Update: A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates [Phase 1]
Summary
A Phase 1 study completed to evaluate the effect of BMS-986142 on the pharmacokinetics of probe substrates in subjects with Rheumatoid Arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED